Study of occurrence of HBeAg among Hepatitis- B surface antigen positive cases

Hepatitis is a universal concept that mean inflammation of the liver and infection with 1 of the 5 viruses called hepatitis A, B, C, D and E viruses is the almost common cause. The 5 viral cause’s hepatitis-B infection is the worldly almost common hepatic infection, which is cause by hepatitis-B (HBV). HBV is a DNA virus. It is 42–47 nm in diameter and enters the liver through with blood stream. HBV is highly contagious and is 60–100 times more than HIV. It is transmissible throughly with blood cell and all body fluid or mucosa membranous. It is transmitted almost normally by unsafe physical sexual contact, contaminated blood transfusions and unsterilized use needles from mother to baby, close household touch and in the midst of children in early childhood. Study of occurrence of HBeAg among Hepatitis- B surface antigen positive cases; 1. Identification of Hepatitis B Surface Antigen positive cases; 2. Occurrence of HBeAg among Hepatitis- B surface antigen positive cases. 5ml blood was collected from anterior cubital vein by Venipuncture from recruited patient. Samples were collected after proper consent and aseptic precautions. Then every blood sample was transfer overhead a tagged tube plane vial The study was conducted in Department of Microbiology, Teerthanker Mahaveer Hospital. Blood sample from 106 patients including both male and female were collected from various department of the Hospital for the analysis purpose. Out of them, 38 (36%) cases were HBeAg positive and 68 (64%) cases were HBeAg negative: The result of our study put up valuable information and connection in HBeAg positive cases. In this little sample size 106 analysis of the patients at Uttar Pradesh Teerthanker Mahaveer Medical College, the prevalence of HBeAg (positive results) in the department of medical microbiology, while the negative result is 68(64%).Males 29(76%) were more affected by the HBV (HBeAg) infection as compare to Female 9(24%).An important preventive measure is the screening for HBV in blood donors. Hepatitis-B related chronic liver disease and hepatocellular carcinoma are best prevented by universal childhood immunization. In non-infected people, HBV infection can be avoided by HBV vaccination.Injections Sequence 3 at 0, 1 and 6 months. In over 90% of recipients vaccination is successful.